✦ LIBER ✦

Renal Cell Carcinoma || Nephron-Sparing Surgery for Renal Cancer

✍ Scribed by Campbell, Steven C.; Rini, Brian I.

Book ID: 120196836
Publisher: Humana Press
Year: 2012
Weight: 642 KB
Category: Article
ISBN: 162703062X
DOI: 10.1007/978-1-62703-062-5_8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

443 IMPACT OF HISTOLOGY ON CANCER CONTRO

443 IMPACT OF HISTOLOGY ON CANCER CONTROL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA

✍ M. Crepel; G. Verhoest; J.C. Bernhard; J.M. Ferriere; L. Bellec; M. Soulie; B. A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 330 KB

MP59-16 RENAL ARTERY PSEUDOANEURYSMS AFT

MP59-16 RENAL ARTERY PSEUDOANEURYSMS AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: INCIDENCE, MANAGEMENT AND FUNCTIONAL OUTCOMES FROM CANADIAN KIDNEY CANCER INFORMATION SYSTEM DATABASE.

✍ Bansal, Rahul; Kapoor, Anil; Finelli, Antonio; Rendon, Ricardo; Moore, Ron; Brea 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 350 KB

Excellent Long-Term Cancer Control with

Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cm

✍ Frank Becker; Stefan Siemer; Markus Hack; Ulrich Humke; Manfred Ziegler; Michael 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Renal cell carcinoma: Considerations for

Renal cell carcinoma: Considerations for nephron-sparing surgery

✍ Seth E. Lerner; Harold Tsai; Robert C. Flanigan; Donald L. Trump; Jonathan Fleis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Nephron-sparing surgery for small renal

Nephron-sparing surgery for small renal cell carcinoma

✍ Yongsheng Li; Shaoxing Zhu; Weizhong Cai; Shiping Chen; Qiyong Li 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 143 KB

Nephron-sparing surgery for small incide

Nephron-sparing surgery for small incidental renal cell carcinoma

✍ Mark Sullivan; Mark Frydenberg 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

**Background**: Nephron‐sparing surgery is currently an accepted treatment for renal cell carcinomas in patients with bilateral tumours, solitary kidneys and when overall renal function is impaired or at risk from medical disease. Its role in patients with a normal contralateral kidney remains contr